Search Results for “EC” – Page 476 – media

Brain Atrophy slowed by Multiple Sclerosis Drug

Ibudilast retarded brain atrophy in 255 advancing multiple scleroses (MS) patients more than a placebo in a National Institute of Health’s (NIH) National Institute of Neurological Disorders and Stroke (NINDS) funded the brain imaging clinical trial. 28 clinical locations were studied for 96 weeks to evaluate the decline in brain atrophy progress. MRI scans were done on the patients’ brains half-yearly. Varied analysis techniques were used as scales to measure the variations in brain alterations seen in the MRI films among the two groups. Brain atrophy was observed in both the groups but the ibudilast group demonstrated the slower rate of shrinkage of the brain. The brain shrunk by 2.5ml more over two years in the group on placebo. NINDS director Walter Koroshetz said, “These findings provide a glimmer of hope for people with a form of multiple sclerosis that causes long-term disability but does not have many treatment options.” ...
- Source: drugdu
- 832
- September 12, 2018
Hospital stay reduced to half with Danish endocarditis plan

A Danish, multicenter, randomized POET trial revealed that after declared clinically stable on taking intravenous antibiotics in a hospital for one to two weeks, left-sided endocarditis patients could be sent home with a prescription of antibiotics to be taken orally to complete the rest of the treatment. “Shifting to oral antibiotic treatment in stabilized patients with endocarditis was as effective and safe as continued intravenous antibiotic treatment and was given during half the antibiotic treatment period. These novel findings may have a significant impact on future clinical practice for the management of patients who are stable,” Henning Bundgård, MD, said at the annual congress of the European Society of Cardiology. Guiding principles from the ESC and American Heart Association/American College of Cardiology suggest 6 weeks of intravenous antibiotics for the management of infective endocarditis. This reduces the stay in the hospital to half resulting in lowering of the expenses borne by ...
- Source: drugdu
- 1,276
- September 11, 2018
Retention in de-addiction therapy increased on administration of medicines.

Medications like buprenorphine, naltrexone, or methadone when added to treatment of opioid use disorder (OUD) youths, resulted in longer adherence to in-care regimen. However, very few receive the medicines, reveals a retrospective cohort study. The study on 4,837 OUD youths between the age 13-22 years including 2,752 females observed that only 1 out of 4 youths and 1 out of 21 adolescents received medication, as reported by Scott E. Hadland, MD, MPH, MS, of Grayken Center for Addiction and Department of Pediatrics, Boston Medical Center, and coinvestigators. The results brought greater attention to the need for better management of OUD in young adults and increase their adherence to treatment, noted Dr. Hadland and co-authors in JAMA Pediatrics. “As deaths from overdose increase among U.S. youths, it is vital that clinicians, researchers, and policy makers ensure that access to evidence-based OUD medications for young people remains a national priority,” they said. The ...
- Source: drugdu
- 974
- September 11, 2018
Crazy cat lady syndrome might also treat cancer

We might have come across many people who are usually obsessed with cats. But at times, this obsession can turn into madness. Where does this madness arise from? There is a research link between the cat parasite named Toxoplasma gondii and the psychiatric disorders like bipolar disorder and schizophrenia. House cats are considered as the primary hosts of Toxoplasma gondii. But according to a study published in Psychological Medicine in 2017, it was reported that just having the cats doesn’t increase the risk of psychosis. It’s the cat parasite that causes psychosis. Later, a research team from Dartmouth College’s Geisel School of Medicine NH, were trying to find the parasite’s immune power against cancer tumors, with the ultimate goal of making a cancer vaccine. Researchers have known that T. gondii infection strongly induces a Th1 immune response, which can increase the cancer survival rates. David J. Bzik, PhD, the lead ...
- Source: drugdu
- 759
- September 11, 2018
Wearable chronic pain reliever app – Quell 2.0

Nearly millions of people throughout the world are living with chronic pain in one form or the other. With the rise of opioids in the epidemic level, there arises a rise in search for new treatment measures. The wearables company named NeuroMetrix had redesigned their device named Quell for an easier and convenient utilization. The modified Quell 2.0 app has taken the FDA approved nerve stimulation technology to the next level, which is supposed to be the latest breakthrough for chronic pain treatment. The Quell 2.0 device is smarter, 50% smaller and 20% more powerful. The new Quell 2.0 app is available online at www.QuellRelief.com. Quell 2.0 app is integrated with a neurostimulation microchip which includes all the features of Quell device. It easily adapts to changes in body position and automatically starts the therapy in switch-on mode. This app is user-friendly with a varied automation feature like start and stop, ...
- Source: drugdu
- 390
- September 11, 2018
Dyspareunia can spoil your sexual life – Act immediately!

A type of physical discomfort where the pain occurs during sexual intercourse is termed as dyspareunia. Even after intercourse, this throbbing pain may last for hours. Pain might occur due to lack of lubrication or infection in genital area. Other emotional causes like stress or history of sexual abuse may also play a major role. Females are more affected compared to males. Sometimes the condition of dyspareunia is often mistaken for lack of interest in the relationship which might cause emotional distress and greater misunderstandings. It’s high time not to feel shy and the need of the hour is to follow five treatment options listed below, to improve sexual life and emotional intimacy. Antibiotic treatment: The major cause of dyspareunia in women is pelvic inflammatory diseases (PID) which is caused due to microbial infections. Hence, the administration of proper antibiotic treatment can cure PID and dyspareunia. Psychological therapy: Psychological counseling ...
- Source: drugdu
- 763
- September 11, 2018
New drug formulation for opioid addiction approved by FDA.

Cassipa, a Teva Phaarmaceuticals manufactured sublingual film containing naloxone and buprenorphine in new dosage amounts, receives FDA approval on the 7th of September as a continuing therapy for opioid addiction. In a press release, the FDA announced that the buprenorphine and naloxone sublingual film, formulated in a 16 mg/4 mg dose for Cassipa, is sanctioned not only in its brand version but also in its generic edition. The two drugs in different strength combinations are also approved by the FDA. A set management protocol including psychotherapy and counseling should comprise of Cassipa post the patient is administered and stabilized with a step-ladder buprenorphine 16 mg dose of another brand. Drug Addiction Treatment Act (DATA) certified professionals only can prescribe these drugs. “There’s an urgent need to ensure access to, and wider use and understanding of, medication-assisted treatment for opioid use disorder … the FDA recently described a streamlined approach to ...
- Source: drugdu
- 1,193
- September 11, 2018
Compressor Nebulizer

A compressor nebulizer is a nebulizer driven by a compressor. Jet nebulizers which are the most commonly used nebulizers are connected by a tube to the compressor. It compresses air and pushes it into the tube which turns the liquid medicine into mist. For the successful delivery of medication to the lungs, a good quality compressor nebulizer must be used. Ddu brings the best-in-class compressor nebulizer suppliers/ manufacturers together. They are Shenzhen Homed Medical Device Co., Ltd., Vega Technologies Inc., Shenzhen Fitconn Technology Co.,ltd., SHENZHEN BI-RICH MEDICAL DEVICES CO.,LTD., Dongguan YHRT Medical Technology Co.,Ltd, AceWin Co., Ltd., and many more. As nebulizers are most frequently used in the paediatric age group, our team has included animal cartoon shaped compressor nebulizers as well. All the nebulizers are made from genuine and high-quality durable parts. They are CE/FDA certified and are have a warranty of minimum 1 year. Paediatric clinics/hospitals can purchase ...
- Source: drugdu
- 386
- September 11, 2018
Vital Signs Monitor

Electronic vital signs monitors are common place in hospitals. It has been 40 years since they have been used to monitor vital signs like heart rate, blood pressure, respiratory rate and SpO2. They are extremely important in ICUs where constant evaluation of vital signs of critical patients is crucial. Ddu (Drugdu.com) offers a vast selection of vital signs monitors. Simple electronic vital signs monitors to hi-tech portable vital signs monitors are assembled by our team. A number of manufacturers/ suppliers present their vital signs monitor on Ddu including General Meditech Inc., Shenzhen Hwatime Biological Medical Electronics Co., Ltd, Shenzhen Viatom Technology Co., Ltd, Better Life Medical, ChoiceMMed, and ShenZhen BOXYM Technology Co., Ltd.Focusing on the Checkme Lite vital signs monitor manufactured by the Shenzhen Viatom Technology Co., Ddu offers its customers with a light-weight portable heart-rate, ECG, SpO2, and blood pressure monitor. It is an easy-to-use portable medical device which ...
- Source: drugdu
- 749
- September 11, 2018
Regular daytime nap might lead to Alzheimer disease

Varied research is going on throughout the world in order to find the cause and treatment for Alzheimer’s disease. Scientists from the National Institute on Aging (NIA), Johns Hopkins Medicine and the Bloomberg School have reported that the elders who often feel sleepy during day time are three times more prone to Alzheimer’s disease. These study findings were recently published in the journal named SLEEP. Alzheimer’s disease occurs due to the development of beta-amyloid plaques in brain which results in the changes of nerve structure. The risk of this disease can be reduced by following proper exercise, diet as well as cognitive activities. Recently it was discovered that sleep pattern is also a major risk factor. Improper sleep can develop beta-amyloid protein accumulation in later stage of life. But the reason behind this mechanism is still unknown. The research team came to know the role of sleep by conducting a ...
- Source: drugdu
- 1,265
- September 10, 2018

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.